Health Outcomes Research in Medicine
Volume 2, Issue 4 , Pages e203-e214 , November 2011

The Burden of Fibromyalgia: Assessment of Health Status Using the EuroQol (EQ-5D) in Patients with Fibromyalgia Relative to Other Chronic Conditions

  • Xuemei Luo, PhD

      Affiliations

    • Global Health Economics & Outcomes Research, Pfizer Inc., New London, Conn
    • Corresponding Author InformationCorresponding Author: Xuemei Luo, PhD, Pfizer Inc., 50 Pequot Avenue, New London, CT 06320.
    • ,
  • Joseph C. Cappelleri, PhD, MPH, MS

      Affiliations

    • Global Research and Development, Pfizer Inc., New London, Conn
    • ,
  • Arthi Chandran, MS, MPH

      Affiliations

    • Global Health Economics & Outcomes Research, Pfizer Inc., New York, NY

References 

  1. Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008;58(1):26–35
  2. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33(2):160–172
  3. Bennett RM. Clinical manifestations and diagnosis of fibromyalgia. Rheum Dis Clin North Am. 2009;35(2):215–232
  4. Mease P, Arnold LM, Choy EH, et al. Fibromyalgia syndrome module at OMERACT 9: domain construct. J Rheumatol. 2009;36(10):2318–2329
  5. Wolfe F, Clauw DJ, Fitzcharles M-A, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62(5):600–610
  6. Annemans L, Le Lay K, Taieb C. Societal and patient burden of fibromyalgia syndrome. Pharmacoeconomics. 2009;27(7):547–559
  7. Hoffman DL, Dukes E. The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int J Clin Pract. 2008;62(1):115–126
  8. Salaffi F, Sarzi-Puttini P, Girolimetti R, Atzeni F, Gasparini S, Grassi W. Health-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey. Clin Exp Rheumatol. 2009;27(5 Suppl 56):S67–S74
  9. Wolfe F, Michaud K, Li T, Katz RS. EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia. J Rheumatol. 2010;37(2):296–304
  10. EuroQol—a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy. 1990;16(3):199–208
  11. Brooks R. EuroQol: the current state of play. Health Policy. 1996;37(1):53–72
  12. Cuatrecasas G, Riudavets C, Guell MA, Nadal A. Growth hormone as concomitant treatment in severe fibromyalgia associated with low IGF-1 serum levels. A pilot study. BMC Musculoskelet Disord. 2007;8:119
  13. Garcia-Campayo J, Serrano-Blanco A, Rodero B, et al. Effectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trial. Trials. 2009;10:24
  14. Gusi N, Tomas-Carus P. Cost-utility of an 8-month aquatic training for women with fibromyalgia: a randomized controlled trial. Arthritis Res Ther. 2008;10(1):R24
  15. Gusi N, Tomas-Carus P, Hakkinen A, Hakkinen K, Ortega-Alonso A. Exercise in waist-high warm water decreases pain and improves health-related quality of life and strength in the lower extremities in women with fibromyalgia. Arthritis Rheum. 2006;55(1):66–73
  16. Kroese M, Schulpen G, Bessems M, Nijhuis F, Severens J, Landewe R. The feasibility and efficacy of a multidisciplinary intervention with aftercare meetings for fibromyalgia. Clin Rheumatol. 2009;28(8):923–929
  17. Perrot S, Dickenson AH, Bennett RM. Fibromyalgia: harmonizing science with clinical practice considerations. Pain Pract. 2008;8(3):177–189
  18. Goldenberg D, Schaefer C, Ryan K, Chandran A, Zlateva G. Can fibromyalgia severity help us to better understand the patient: results from a cross-sectional survey in the United States. [abstract] J Pain. 2010;11(4):S4
  19. Agency for Healthcare Research and Quality. Medical Expenditure Panel Survey. Available at: http://www.meps.ahrq.gov/mepsweb/. Accessed September 2011.
  20. Agency for Healthcare Research and Quality. Calculating the U.S. population-based EQ-5D index score. Available at: http://www.ahrq.gov/rice/EQ5Dscore.htm. Accessed September 2011.
  21. Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005;43(3):203–220
  22. SAS Institute. SAS/STAT User’s Guide. Version 9.2 Cary, NC: SAS Institute; 2008;
  23. Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res. 2005;14(6):1523–1532
  24. Sullivan PW, Lawrence WF, Ghushchyan V. A national catalog of preference-based scores for chronic conditions in the United States. Med Care. 2005;43(7):736–749
  25. Sullivan PW, Ghushchyan V. Preference-based EQ-5D index scores for chronic conditions in the United States. Med Decis Making. 2006;26(4):410–420
  26. Perrot S, Winkelmann A, Dukes E, et al. Characteristics of patients with fibromyalgia in France and Germany. Int J Clin Pract. 2010;64(8):1100–1108
  27. Johnson JA, Luo N, Shaw JE, Kind P, Coons SJ. Valuations of EQ-5D health states: are the United States and United Kingdom different?. Med Care. 2005;43:221–228
  28. Silverman S, Sadosky A, Evans C, Yeh Y, Alvir J, Zlateva G. Toward characterization and definition of fibromyalgia severity. BMC Musculoskelet Disord. 2010;11:66
  29. Sadosky A, Bushmakin A, Cappelleri JC, Lionberger DR. Relationship between patient-reported disease severity in osteoarthritis and self-reported pain, function, and work productivity. Arthritis Res Ther. 2010;12:R162
  30. Taylor-Stokes G, Ross E, Lobosco S, Pike J, Sadosky A. Relationship of patient-reported chronic low back pain severity with other patient-reported outcomes. [abstract] Reg Anesth Pain Med. 2010;35(Suppl):Abstract #99
  31. Bennett RM, Jones J, Turk DC, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord. 2007;8:27
  32. Reisine S, Fifield J, Walsh SJ, Feinn R. Do employment and family work affect the health status of women with fibromyalgia?. J Rheumatol. 2003;30(9):2045–2053
  33. Reisine S, Fifield J, Walsh S, Dauser D. Employment and quality of life outcomes among women with fibromyalgia compared to healthy controls. Women Health. 2004;39(4):1–19
  34. Reisine S, Fifield J, Walsh S, Forrest DD. Employment and health status changes among women with fibromyalgia: a five-year study. Arthritis Rheum. 2008;59(12):1735–1741
  35. Stewart AL, Napoles-Springer A. Health-related quality-of-life assessments in diverse population groups in the United States. Med Care. 2000;38(9 Suppl):II102–II124

 The research reported in this article was funded by Pfizer Inc. Xuemei Luo, Joseph C. Cappelleri, and Arthi Chandran are all employees and stockholders of Pfizer, Inc., the sponsor of this study.

PII: S1877-1319(11)00027-9

doi: 10.1016/j.ehrm.2011.08.002

Health Outcomes Research in Medicine
Volume 2, Issue 4 , Pages e203-e214 , November 2011

Article Tools

* Image Usage & Resolution